Protease sales will strengthen through 2036, anchored by microbial proteases at 72.6% of the source segment in 2026. The market is projected to grow from USD 2.6 billion in 2026 to USD 5.7 billion by 2036, creating an incremental opportunity of USD 3.1 billion between 2026 and 2036.